HEADER HYDROLASE/ISOMERASE/IMMUNOSUPPRESSANT 09-AUG-02 1MF8 TITLE CRYSTAL STRUCTURE OF HUMAN CALCINEURIN COMPLEXED WITH CYCLOSPORIN A TITLE 2 AND HUMAN CYCLOPHILIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: CALMODULIN-DEPENDENT CALCINEURIN A SUBUNIT, ALPHA ISOFORM; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: TRUNCATED FORM (RESIDUES 20-392); COMPND 5 SYNONYM: SERINE/THREONINE PROTEIN PHOSPHATASE 2B CATALYTIC SUBUNIT COMPND 6 ALPHA ISOFORM, CAM-PRP CATALYTIC SUBUNIT; COMPND 7 EC: 3.1.3.16; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: CALCINEURIN B SUBUNIT ISOFORM 1; COMPND 11 CHAIN: B; COMPND 12 SYNONYM: PROTEIN PHOSPHATASE 2B REGULATORY SUBUNIT 1, PROTEIN COMPND 13 PHOSPHATASE 3 REGULATORY SUBUNIT B ALPHA ISOFORM 1; COMPND 14 EC: 3.1.3.16; COMPND 15 ENGINEERED: YES; COMPND 16 MOL_ID: 3; COMPND 17 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A; COMPND 18 CHAIN: C; COMPND 19 SYNONYM: PPIASE, ROTAMASE, CYCLOPHILIN A; COMPND 20 EC: 5.2.1.8; COMPND 21 ENGINEERED: YES; COMPND 22 MOL_ID: 4; COMPND 23 MOLECULE: CYCLOSPORIN A; COMPND 24 CHAIN: D; COMPND 25 SYNONYM: CYCLOSPORINE, CICLOSPORIN, CICLOSPORINE; COMPND 26 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) PLYSS; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PETCN ALPHA; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) PLYSS; SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PETCN ALPHA; SOURCE 19 MOL_ID: 3; SOURCE 20 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 21 ORGANISM_COMMON: HUMAN; SOURCE 22 ORGANISM_TAXID: 9606; SOURCE 23 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 24 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 25 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) CODONPLUS RIL; SOURCE 26 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 27 EXPRESSION_SYSTEM_PLASMID: PET3A.CYPA; SOURCE 28 MOL_ID: 4; SOURCE 29 SYNTHETIC: YES; SOURCE 30 ORGANISM_SCIENTIFIC: TOLYPOCLADIUM INFLATUM; SOURCE 31 ORGANISM_TAXID: 29910 KEYWDS HYDROLASE-ISOMERASE-IMMUNOSUPPRESSANT COMPLEX, CALCINEURIN- KEYWDS 2 CYCLOPHILIN-CYCLOSPORIN COMPLEX, CYCLOSPORIN A, IMMUNOSUPPRESSANT, KEYWDS 3 HYDROLASE, ISOMERASE EXPDTA X-RAY DIFFRACTION AUTHOR L.JIN,S.C.HARRISON REVDAT 5 27-JUL-11 1MF8 1 REMARK REVDAT 4 13-JUL-11 1MF8 1 VERSN REVDAT 3 24-FEB-09 1MF8 1 VERSN REVDAT 2 23-OCT-02 1MF8 1 JRNL REVDAT 1 16-OCT-02 1MF8 0 JRNL AUTH L.JIN,S.C.HARRISON JRNL TITL CRYSTAL STRUCTURE OF HUMAN CALCINEURIN COMPLEXED WITH JRNL TITL 2 CYCLOSPORIN A AND HUMAN CYCLOPHILIN JRNL REF PROC.NATL.ACAD.SCI.USA V. 99 13522 2002 JRNL REFN ISSN 0027-8424 JRNL PMID 12357034 JRNL DOI 10.1073/PNAS.212504399 REMARK 2 REMARK 2 RESOLUTION. 3.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.6 REMARK 3 NUMBER OF REFLECTIONS : 14195 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.250 REMARK 3 FREE R VALUE : 0.300 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1052 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5513 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 9 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.50 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1MF8 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-AUG-02. REMARK 100 THE RCSB ID CODE IS RCSB016869. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-MAR-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CHESS REMARK 200 BEAMLINE : F1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91611 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14195 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.100 REMARK 200 RESOLUTION RANGE LOW (A) : 15.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.6 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07700 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 19.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.21 REMARK 200 COMPLETENESS FOR SHELL (%) : 81.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.37000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1AUI AND 2RMA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% PEG 4000, 5MM POTASSIUM PHOSPHATE, REMARK 280 75MM SODIUM CITRATE, 15% GLYCEROL, 5MM TRIS, PH 4.6, MICROBATCH, REMARK 280 TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.47450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 56.42050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 54.16700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 56.42050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.47450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 54.16700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7390 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 28770 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -91.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. REMARK 400 HERE, CYCLOSPORIN A IS REPRESENTED BY THE SEQUENCE (SEQRES) REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: CYCLOSPORIN A REMARK 400 CHAIN: D REMARK 400 COMPONENT_1: PEPTIDE LIKE SEQUENCE RESIDUES 1 TO 11 REMARK 400 DESCRIPTION: CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. REMARK 400 CYCLIZATION IS ACHIEVED BY LINKING THE N- AND REMARK 400 THE C- TERMINI. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 CYS A 372 REMARK 465 SER A 373 REMARK 465 ASP A 374 REMARK 465 ASP A 375 REMARK 465 GLU A 376 REMARK 465 LEU A 377 REMARK 465 GLY A 378 REMARK 465 SER A 379 REMARK 465 GLU A 380 REMARK 465 GLU A 381 REMARK 465 ASP A 382 REMARK 465 GLY A 383 REMARK 465 PHE A 384 REMARK 465 ASP A 385 REMARK 465 GLY A 386 REMARK 465 ALA A 387 REMARK 465 THR A 388 REMARK 465 ALA A 389 REMARK 465 ALA A 390 REMARK 465 ALA A 391 REMARK 465 ARG A 392 REMARK 465 MET B 0 REMARK 465 GLY B 1 REMARK 465 ASN B 2 REMARK 465 GLU B 3 REMARK 465 ALA B 4 REMARK 465 VAL B 169 REMARK 465 GLU C 165 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 SER A 26 OG REMARK 480 LYS A 32 CE NZ REMARK 480 LYS A 76 CE NZ REMARK 480 ASN A 110 OD1 ND2 REMARK 480 GLU A 158 CG CD OE1 OE2 REMARK 480 SER A 233 OG REMARK 480 GLU A 237 CD OE1 OE2 REMARK 480 LYS A 243 CG CD CE NZ REMARK 480 GLN A 245 CG CD OE1 NE2 REMARK 480 THR A 252 OG1 REMARK 480 GLN A 295 CG CD OE1 NE2 REMARK 480 ASN A 316 CG OD1 ND2 REMARK 480 LYS B 20 CD CE NZ REMARK 480 LYS B 27 NZ REMARK 480 LYS B 28 CD CE NZ REMARK 480 SER B 36 OG REMARK 480 GLU B 40 CG CD OE1 OE2 REMARK 480 MET B 43 CE REMARK 480 GLU B 47 CG CD OE1 OE2 REMARK 480 GLN B 49 CG CD OE1 NE2 REMARK 480 LYS B 84 NZ REMARK 480 LYS B 124 CD CE NZ REMARK 480 LYS B 141 CG CD CE NZ REMARK 480 GLU B 150 CG CD OE1 OE2 REMARK 480 LYS B 163 NZ REMARK 480 LYS B 164 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 29 147.14 -38.89 REMARK 500 LEU A 46 -74.61 -36.40 REMARK 500 LYS A 47 -37.64 -36.00 REMARK 500 GLU A 53 4.28 84.25 REMARK 500 HIS A 92 55.05 38.46 REMARK 500 LEU A 114 110.58 -170.70 REMARK 500 ASP A 118 67.96 71.38 REMARK 500 ASP A 121 160.20 68.27 REMARK 500 ARG A 122 -70.37 79.63 REMARK 500 THR A 143 -59.75 -123.46 REMARK 500 CYS A 153 145.38 -170.13 REMARK 500 TYR A 170 -104.07 -125.02 REMARK 500 ALA A 188 -167.79 -165.66 REMARK 500 ASN A 192 46.22 36.36 REMARK 500 GLN A 193 17.37 43.47 REMARK 500 GLN A 245 38.11 -93.54 REMARK 500 HIS A 247 -77.01 -82.86 REMARK 500 SER A 257 -148.54 59.60 REMARK 500 ALA A 280 -126.71 -110.65 REMARK 500 HIS A 281 -49.50 80.04 REMARK 500 TYR A 288 169.20 173.70 REMARK 500 ARG A 292 139.87 -35.98 REMARK 500 ASP A 313 -0.51 72.44 REMARK 500 TYR B 6 98.71 75.25 REMARK 500 GLN B 50 63.62 -115.57 REMARK 500 ASP C 13 10.32 80.63 REMARK 500 GLU C 43 -7.51 -45.79 REMARK 500 PHE C 60 -78.72 -121.84 REMARK 500 GLU C 81 -46.57 -29.79 REMARK 500 GLU C 84 167.56 -49.75 REMARK 500 GLU C 86 -75.59 -50.02 REMARK 500 PRO C 95 162.59 -49.25 REMARK 500 THR C 107 34.43 -143.49 REMARK 500 ARG C 148 3.46 -69.04 REMARK 500 ILE C 158 74.41 -101.67 REMARK 500 MLE D 2 79.60 -112.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA B 401 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 30 OD1 REMARK 620 2 SER B 36 O 102.7 REMARK 620 3 GLU B 41 OE1 93.5 103.7 REMARK 620 4 GLU B 41 OE2 140.1 106.9 53.9 REMARK 620 5 SER B 34 OG 97.8 72.6 168.6 116.1 REMARK 620 6 ASP B 32 OD1 101.0 141.3 104.8 71.0 74.3 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA B 402 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU B 73 OE2 REMARK 620 2 ASP B 64 OD1 72.0 REMARK 620 3 ASN B 66 OD1 164.2 92.4 REMARK 620 4 GLU B 68 O 121.0 163.6 74.7 REMARK 620 5 GLU B 73 OE1 56.7 123.6 136.0 72.6 REMARK 620 6 ASP B 62 OD1 99.0 93.2 83.6 75.5 115.1 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA B 403 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 99 OD1 REMARK 620 2 ASP B 103 OD1 67.0 REMARK 620 3 GLU B 110 OE2 120.4 155.5 REMARK 620 4 GLU B 110 OE1 101.0 149.7 54.8 REMARK 620 5 TYR B 105 O 54.2 72.6 131.5 77.9 REMARK 620 6 ASP B 101 OD1 106.9 62.0 94.0 146.2 134.4 REMARK 620 7 ASP B 101 OD2 153.2 100.6 61.9 100.5 147.4 47.9 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA B 404 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ARG B 146 O REMARK 620 2 ASP B 140 OD1 100.9 REMARK 620 3 ASP B 144 OD1 78.5 79.2 REMARK 620 4 ASP B 142 OD1 157.3 75.0 78.9 REMARK 620 5 GLU B 151 OE2 127.4 113.9 143.7 73.0 REMARK 620 6 GLU B 151 OE1 76.4 131.9 143.0 123.3 51.1 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA B 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA B 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA B 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 393 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF CYCLOSPORIN A REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AUI RELATED DB: PDB REMARK 900 HUMAN CALCINEURIN STRUCTURE REMARK 900 RELATED ID: 1BCK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH REMARK 900 CYCLOSPORIN C REMARK 900 RELATED ID: 1C5F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CYCLOPHILIN-LIKE DOMAIN FROM REMARK 900 BRUGIA MALAYI COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1CSA RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF E.COLI CYCLOPHILIN (F112W) COMPLEXED REMARK 900 WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1CWA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 1CWB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH REMARK 900 MODIFIED CYCLOSPORIN A AT POSITION 5 REMARK 900 RELATED ID: 1CWC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH REMARK 900 MODIFIED CYCLOSPORIN A AT POSITION 8 REMARK 900 RELATED ID: 1CWF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH REMARK 900 CYCLOSPORIN D REMARK 900 RELATED ID: 1CWH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH REMARK 900 CYCLOSPORIN A MODIFIED AT POSITION 7 REMARK 900 RELATED ID: 1CWI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH REMARK 900 MODIFIED CYCLOSPORIN D AT POSITION 7 REMARK 900 RELATED ID: 1CWJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH REMARK 900 MODIFIED CYCLOSPORIN D AT POSITIONS 5 AND 7. REMARK 900 RELATED ID: 1CWK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH REMARK 900 MODIFIED CYCLOSPORIN D AT POSITIONS 5 AND 7. REMARK 900 RELATED ID: 1CWL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH REMARK 900 MODIFIED CYCLOSPORIN A AT POSITION 8 REMARK 900 RELATED ID: 1CWM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH REMARK 900 MODIFIED CYCLOSPORIN A AT POSITION 8 REMARK 900 RELATED ID: 1CWO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH REMARK 900 NODIFIED CYCLOSPORIN C AT POSITIONS 1, AND 9 REMARK 900 RELATED ID: 1CYA RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF HUMAN CYCLOPHILIN COMPLEXED WIYH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 1CYB RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF HUMAN CYCLOPHILIN COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 1CYN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN B COMPLEXED WITH REMARK 900 MODIFIED CYCLOSPORIN A REMARK 900 RELATED ID: 1IKF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CTCLOSPORIN-FAB COMPLEX REMARK 900 RELATED ID: 1M63 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CALCINEURIN-CYCLOPHILIN-CYCLOSPORIN REMARK 900 COMPLEX REMARK 900 RELATED ID: 1MIK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH REMARK 900 MODIFIED CYCLOSPORIN A AT POSITION 6 REMARK 900 RELATED ID: 1QNG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM CYCLOPHILIN REMARK 900 COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1QNH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM CYCLOPHILIN REMARK 900 (DOUBLE MUTANT) COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1XQ7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYCLOPHILIN REMARK 900 COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 2ESL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN C COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 2OJU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN J COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 2POY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CRYPTOSPORIDIUM PARVUM IOWA II REMARK 900 CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 2RMA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 2RMB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH REMARK 900 MODIFIED CYCLOSPORIN A AT POSITION 5 REMARK 900 RELATED ID: 2RMC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MURINE CYCLOPHILIN C COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 2WFJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PPIASE DOMAIN OF HUMAN CYCLOPHILIN REMARK 900 G COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 2X2C RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ACETYL-CYPA COMPLEXED WITH REMARK 900 CYCLOSPORINE A REMARK 900 RELATED ID: 2X7K RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PPIL1 COMPLEXED WITH CYCLOSPORINE A REMARK 900 RELATED ID: 2Z6W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN D IN COMPLEX WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 3BO7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CYCLOSPHILIN A FROM TOXOPLASMA GONDII REMARK 900 COMPLEXED WIT CYCLOSPORIN A REMARK 900 RELATED ID: 3CYS RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE HUMAN CYCLOSPORIN A COMPLEXED REMARK 900 WITH CYCLOSPORIN A REMARK 900 RELATED ID: 3EOV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CYCLOPHILIN FROM LEISHMANIA DONOVANI REMARK 900 COMPLEXED WITH CYCLOSPORIN A DBREF 1MF8 A 20 392 UNP Q08209 P2BA_HUMAN 20 392 DBREF 1MF8 B 0 169 UNP P63098 CANB1_HUMAN 0 169 DBREF 1MF8 C 1 165 UNP P62937 PPIA_HUMAN 0 164 DBREF 1MF8 D 1 11 NOR NOR00033 NOR00033 1 11 SEQRES 1 A 373 ALA VAL PRO PHE PRO PRO SER HIS ARG LEU THR ALA LYS SEQRES 2 A 373 GLU VAL PHE ASP ASN ASP GLY LYS PRO ARG VAL ASP ILE SEQRES 3 A 373 LEU LYS ALA HIS LEU MET LYS GLU GLY ARG LEU GLU GLU SEQRES 4 A 373 SER VAL ALA LEU ARG ILE ILE THR GLU GLY ALA SER ILE SEQRES 5 A 373 LEU ARG GLN GLU LYS ASN LEU LEU ASP ILE ASP ALA PRO SEQRES 6 A 373 VAL THR VAL CYS GLY ASP ILE HIS GLY GLN PHE PHE ASP SEQRES 7 A 373 LEU MET LYS LEU PHE GLU VAL GLY GLY SER PRO ALA ASN SEQRES 8 A 373 THR ARG TYR LEU PHE LEU GLY ASP TYR VAL ASP ARG GLY SEQRES 9 A 373 TYR PHE SER ILE GLU CYS VAL LEU TYR LEU TRP ALA LEU SEQRES 10 A 373 LYS ILE LEU TYR PRO LYS THR LEU PHE LEU LEU ARG GLY SEQRES 11 A 373 ASN HIS GLU CYS ARG HIS LEU THR GLU TYR PHE THR PHE SEQRES 12 A 373 LYS GLN GLU CYS LYS ILE LYS TYR SER GLU ARG VAL TYR SEQRES 13 A 373 ASP ALA CYS MET ASP ALA PHE ASP CYS LEU PRO LEU ALA SEQRES 14 A 373 ALA LEU MET ASN GLN GLN PHE LEU CYS VAL HIS GLY GLY SEQRES 15 A 373 LEU SER PRO GLU ILE ASN THR LEU ASP ASP ILE ARG LYS SEQRES 16 A 373 LEU ASP ARG PHE LYS GLU PRO PRO ALA TYR GLY PRO MET SEQRES 17 A 373 CYS ASP ILE LEU TRP SER ASP PRO LEU GLU ASP PHE GLY SEQRES 18 A 373 ASN GLU LYS THR GLN GLU HIS PHE THR HIS ASN THR VAL SEQRES 19 A 373 ARG GLY CYS SER TYR PHE TYR SER TYR PRO ALA VAL CYS SEQRES 20 A 373 GLU PHE LEU GLN HIS ASN ASN LEU LEU SER ILE LEU ARG SEQRES 21 A 373 ALA HIS GLU ALA GLN ASP ALA GLY TYR ARG MET TYR ARG SEQRES 22 A 373 LYS SER GLN THR THR GLY PHE PRO SER LEU ILE THR ILE SEQRES 23 A 373 PHE SER ALA PRO ASN TYR LEU ASP VAL TYR ASN ASN LYS SEQRES 24 A 373 ALA ALA VAL LEU LYS TYR GLU ASN ASN VAL MET ASN ILE SEQRES 25 A 373 ARG GLN PHE ASN CYS SER PRO HIS PRO TYR TRP LEU PRO SEQRES 26 A 373 ASN PHE MET ASP VAL PHE THR TRP SER LEU PRO PHE VAL SEQRES 27 A 373 GLY GLU LYS VAL THR GLU MET LEU VAL ASN VAL LEU ASN SEQRES 28 A 373 ILE CYS SER ASP ASP GLU LEU GLY SER GLU GLU ASP GLY SEQRES 29 A 373 PHE ASP GLY ALA THR ALA ALA ALA ARG SEQRES 1 B 170 MET GLY ASN GLU ALA SER TYR PRO LEU GLU MET CYS SER SEQRES 2 B 170 HIS PHE ASP ALA ASP GLU ILE LYS ARG LEU GLY LYS ARG SEQRES 3 B 170 PHE LYS LYS LEU ASP LEU ASP ASN SER GLY SER LEU SER SEQRES 4 B 170 VAL GLU GLU PHE MET SER LEU PRO GLU LEU GLN GLN ASN SEQRES 5 B 170 PRO LEU VAL GLN ARG VAL ILE ASP ILE PHE ASP THR ASP SEQRES 6 B 170 GLY ASN GLY GLU VAL ASP PHE LYS GLU PHE ILE GLU GLY SEQRES 7 B 170 VAL SER GLN PHE SER VAL LYS GLY ASP LYS GLU GLN LYS SEQRES 8 B 170 LEU ARG PHE ALA PHE ARG ILE TYR ASP MET ASP LYS ASP SEQRES 9 B 170 GLY TYR ILE SER ASN GLY GLU LEU PHE GLN VAL LEU LYS SEQRES 10 B 170 MET MET VAL GLY ASN ASN LEU LYS ASP THR GLN LEU GLN SEQRES 11 B 170 GLN ILE VAL ASP LYS THR ILE ILE ASN ALA ASP LYS ASP SEQRES 12 B 170 GLY ASP GLY ARG ILE SER PHE GLU GLU PHE CYS ALA VAL SEQRES 13 B 170 VAL GLY GLY LEU ASP ILE HIS LYS LYS MET VAL VAL ASP SEQRES 14 B 170 VAL SEQRES 1 C 165 MET VAL ASN PRO THR VAL PHE PHE ASP ILE ALA VAL ASP SEQRES 2 C 165 GLY GLU PRO LEU GLY ARG VAL SER PHE GLU LEU PHE ALA SEQRES 3 C 165 ASP LYS VAL PRO LYS THR ALA GLU ASN PHE ARG ALA LEU SEQRES 4 C 165 SER THR GLY GLU LYS GLY PHE GLY TYR LYS GLY SER CYS SEQRES 5 C 165 PHE HIS ARG ILE ILE PRO GLY PHE MET CYS GLN GLY GLY SEQRES 6 C 165 ASP PHE THR ARG HIS ASN GLY THR GLY GLY LYS SER ILE SEQRES 7 C 165 TYR GLY GLU LYS PHE GLU ASP GLU ASN PHE ILE LEU LYS SEQRES 8 C 165 HIS THR GLY PRO GLY ILE LEU SER MET ALA ASN ALA GLY SEQRES 9 C 165 PRO ASN THR ASN GLY SER GLN PHE PHE ILE CYS THR ALA SEQRES 10 C 165 LYS THR GLU TRP LEU ASP GLY LYS HIS VAL VAL PHE GLY SEQRES 11 C 165 LYS VAL LYS GLU GLY MET ASN ILE VAL GLU ALA MET GLU SEQRES 12 C 165 ARG PHE GLY SER ARG ASN GLY LYS THR SER LYS LYS ILE SEQRES 13 C 165 THR ILE ALA ASP CYS GLY GLN LEU GLU SEQRES 1 D 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA HET DAL D 1 5 HET MLE D 2 9 HET MLE D 3 9 HET MVA D 4 8 HET BMT D 5 13 HET ABA D 6 6 HET SAR D 7 5 HET MLE D 8 9 HET MLE D 10 9 HET CA B 401 1 HET CA B 402 1 HET CA B 403 1 HET CA B 404 1 HET PO4 A 393 5 HETNAM DAL D-ALANINE HETNAM MLE N-METHYLLEUCINE HETNAM MVA N-METHYLVALINE HETNAM BMT 4-METHYL-4-[(E)-2-BUTENYL]-4,N-METHYL-THREONINE HETNAM ABA ALPHA-AMINOBUTYRIC ACID HETNAM SAR SARCOSINE HETNAM CA CALCIUM ION HETNAM PO4 PHOSPHATE ION FORMUL 4 DAL C3 H7 N O2 FORMUL 4 MLE 4(C7 H15 N O2) FORMUL 4 MVA C6 H13 N O2 FORMUL 4 BMT C10 H19 N O3 FORMUL 4 ABA C4 H9 N O2 FORMUL 4 SAR C3 H7 N O2 FORMUL 5 CA 4(CA 2+) FORMUL 9 PO4 O4 P 3- HELIX 1 1 THR A 30 PHE A 35 1 6 HELIX 2 2 ARG A 42 MET A 51 1 10 HELIX 3 3 GLU A 57 GLU A 75 1 19 HELIX 4 4 GLN A 94 GLY A 106 1 13 HELIX 5 5 PHE A 125 TYR A 140 1 16 HELIX 6 6 CYS A 153 PHE A 160 1 8 HELIX 7 7 THR A 161 TYR A 170 1 10 HELIX 8 8 SER A 171 ASP A 183 1 13 HELIX 9 9 THR A 208 LEU A 215 1 8 HELIX 10 10 GLY A 225 SER A 233 1 9 HELIX 11 11 SER A 261 ASN A 272 1 12 HELIX 12 12 ASN A 310 VAL A 314 5 5 HELIX 13 13 LEU A 343 MET A 347 5 5 HELIX 14 14 ASP A 348 ASN A 370 1 23 HELIX 15 15 ASP B 15 ASP B 30 1 16 HELIX 16 16 SER B 38 MET B 43 1 6 HELIX 17 17 SER B 44 GLN B 49 5 6 HELIX 18 18 LEU B 53 ASP B 62 1 10 HELIX 19 19 PHE B 71 SER B 79 1 9 HELIX 20 20 GLN B 80 SER B 82 5 3 HELIX 21 21 ASP B 86 ASP B 99 1 14 HELIX 22 22 SER B 107 GLY B 120 1 14 HELIX 23 23 LYS B 124 ASP B 140 1 17 HELIX 24 24 PHE B 149 GLY B 157 1 9 HELIX 25 25 GLY B 158 LYS B 164 5 7 HELIX 26 26 VAL C 29 GLY C 42 1 14 HELIX 27 27 THR C 119 LEU C 122 5 4 HELIX 28 28 GLY C 135 ARG C 144 1 10 SHEET 1 AA 6 LEU A 78 ILE A 81 0 SHEET 2 AA 6 ALA A 188 MET A 191 1 O ALA A 188 N LEU A 79 SHEET 3 AA 6 PHE A 195 CYS A 197 -1 O PHE A 195 N MET A 191 SHEET 4 AA 6 SER A 276 ARG A 279 1 O SER A 276 N LEU A 196 SHEET 5 AA 6 LEU A 302 ILE A 305 1 O ILE A 303 N ARG A 279 SHEET 6 AA 6 TYR A 288 MET A 290 -1 O ARG A 289 N THR A 304 SHEET 1 AB 4 ARG A 112 PHE A 115 0 SHEET 2 AB 4 VAL A 85 CYS A 88 1 O THR A 86 N LEU A 114 SHEET 3 AB 4 ALA A 319 GLU A 325 -1 O LEU A 322 N VAL A 87 SHEET 4 AB 4 VAL A 328 PHE A 334 -1 O VAL A 328 N GLU A 325 SHEET 1 AC 3 ASP A 234 PRO A 235 0 SHEET 2 AC 3 TYR A 258 TYR A 260 1 O TYR A 258 N ASP A 234 SHEET 3 AC 3 THR A 249 HIS A 250 -1 O THR A 249 N PHE A 259 SHEET 1 BA 2 SER B 36 LEU B 37 0 SHEET 2 BA 2 VAL B 69 ASP B 70 -1 O VAL B 69 N LEU B 37 SHEET 1 BB 2 TYR B 105 ILE B 106 0 SHEET 2 BB 2 ILE B 147 SER B 148 -1 O ILE B 147 N ILE B 106 SHEET 1 CA 8 ARG C 55 ILE C 57 0 SHEET 2 CA 8 MET C 61 GLY C 64 -1 O MET C 61 N ILE C 57 SHEET 3 CA 8 PHE C 112 CYS C 115 -1 O PHE C 112 N GLY C 64 SHEET 4 CA 8 ILE C 97 MET C 100 -1 O ILE C 97 N CYS C 115 SHEET 5 CA 8 VAL C 128 GLU C 134 -1 N PHE C 129 O LEU C 98 SHEET 6 CA 8 GLU C 15 LEU C 24 -1 O SER C 21 N LYS C 133 SHEET 7 CA 8 THR C 5 VAL C 12 -1 O VAL C 6 N PHE C 22 SHEET 8 CA 8 ILE C 156 GLN C 163 -1 O THR C 157 N ALA C 11 LINK CA CA B 401 OD1 ASP B 30 1555 1555 2.14 LINK CA CA B 401 O SER B 36 1555 1555 2.65 LINK CA CA B 401 OE1 GLU B 41 1555 1555 2.40 LINK CA CA B 401 OE2 GLU B 41 1555 1555 2.45 LINK CA CA B 401 OG SER B 34 1555 1555 3.06 LINK CA CA B 401 OD1 ASP B 32 1555 1555 2.16 LINK CA CA B 402 OE2 GLU B 73 1555 1555 2.33 LINK CA CA B 402 OD1 ASP B 64 1555 1555 2.13 LINK CA CA B 402 OD1 ASN B 66 1555 1555 2.43 LINK CA CA B 402 O GLU B 68 1555 1555 2.37 LINK CA CA B 402 OE1 GLU B 73 1555 1555 2.31 LINK CA CA B 402 OD1 ASP B 62 1555 1555 2.47 LINK CA CA B 403 OD1 ASP B 99 1555 1555 2.33 LINK CA CA B 403 OD1 ASP B 103 1555 1555 2.34 LINK CA CA B 403 OE2 GLU B 110 1555 1555 2.61 LINK CA CA B 403 OE1 GLU B 110 1555 1555 2.10 LINK CA CA B 403 O TYR B 105 1555 1555 2.72 LINK CA CA B 403 OD1 ASP B 101 1555 1555 2.65 LINK CA CA B 403 OD2 ASP B 101 1555 1555 2.78 LINK CA CA B 404 O ARG B 146 1555 1555 2.25 LINK CA CA B 404 OD1 ASP B 140 1555 1555 2.38 LINK CA CA B 404 OD1 ASP B 144 1555 1555 1.96 LINK CA CA B 404 OD1 ASP B 142 1555 1555 1.92 LINK CA CA B 404 OE2 GLU B 151 1555 1555 2.56 LINK CA CA B 404 OE1 GLU B 151 1555 1555 2.50 LINK C DAL D 1 N MLE D 2 1555 1555 1.35 LINK N DAL D 1 C ALA D 11 1555 1555 1.33 LINK C MLE D 2 N MLE D 3 1555 1555 1.35 LINK C MLE D 3 N MVA D 4 1555 1555 1.36 LINK C MVA D 4 N BMT D 5 1555 1555 1.34 LINK C BMT D 5 N ABA D 6 1555 1555 1.34 LINK C ABA D 6 N SAR D 7 1555 1555 1.34 LINK C SAR D 7 N MLE D 8 1555 1555 1.34 LINK C MLE D 8 N VAL D 9 1555 1555 1.33 LINK C VAL D 9 N MLE D 10 1555 1555 1.35 LINK C MLE D 10 N ALA D 11 1555 1555 1.33 CISPEP 1 ALA A 83 PRO A 84 0 1.30 SITE 1 AC1 5 ASP B 30 ASP B 32 SER B 34 SER B 36 SITE 2 AC1 5 GLU B 41 SITE 1 AC2 5 ASP B 62 ASP B 64 ASN B 66 GLU B 68 SITE 2 AC2 5 GLU B 73 SITE 1 AC3 5 ASP B 99 ASP B 101 ASP B 103 TYR B 105 SITE 2 AC3 5 GLU B 110 SITE 1 AC4 5 ASP B 140 ASP B 142 ASP B 144 ARG B 146 SITE 2 AC4 5 GLU B 151 SITE 1 AC5 2 ARG A 122 TYR A 311 SITE 1 AC6 20 LEU A 312 VAL A 314 TYR A 341 TRP A 342 SITE 2 AC6 20 LEU A 343 PRO A 344 TRP A 352 PHE A 356 SITE 3 AC6 20 ASN B 122 ARG C 55 PHE C 60 GLN C 63 SITE 4 AC6 20 GLY C 72 ALA C 101 ASN C 102 ALA C 103 SITE 5 AC6 20 GLN C 111 PHE C 113 TRP C 121 HIS C 126 CRYST1 64.949 108.334 112.841 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015397 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009231 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008862 0.00000